SciELO - Scientific Electronic Library Online

 
vol.32 issue2Current treatment and new therapies against chronic hepatitis B virus infectionThe Current View of Endoscopic procedures and Antithrombotic Therapies author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Gastroenterologia

Print version ISSN 0120-9957

Abstract

CORIAT B, Jeanette et al. A Review of the Literature on the Use of Probiotics to Treat Irritable Bowel Syndrome and Inflammatory Bowel Disease. Rev Col Gastroenterol [online]. 2017, vol.32, n.2, pp.141-149. ISSN 0120-9957.  http://dx.doi.org/10.22516/25007440.141.

Introduction:

Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are frequent reasons for medical consultation. Usually they are treated at the first level of attention with adjustment of lifestyle and dietary changes. Pharmacological treatments have limited efficacy and significant side effects, so there is growing interest in other therapies such as the use of probiotics.

Methods:

This is literature review of studies associating nutritional supplements with IBS or IBD that have an emphasis on probiotics and which found in the Medline and Embase databases.

Results:

Of a total of 1,598 references, 43 met the final inclusion criteria. The use of probiotics in IBS and IBD suggests a therapy that helps maintain periods of disease remission, improvement of quality of life and attenuation of the pathophysiological process.

Conclusions:

The use of probiotics and prebiotics could be alternative nutritional support for selected patients.

Keywords : Inflammatory bowel diseases; nutritional status; probiotics; irritable bowel syndrome; dietary supplements.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )